Entera Bio (ENTX) Earnings Date & Reports

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ENTX is expected to report earnings to fall 42.86% to -7 cents per share on November 05

Q3'26

Est.

$-0.08

Q2'26

Missed

by $0.05

Q1'26

Beat

by $0.04

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.16

The last earnings report on August 10 showed earnings per share of -14 cents, missing the estimate of -9 cents. With 234.03K shares outstanding, the current market capitalization sits at 559.25M.

View a ticker or compare two or three

ENTX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days